Epigallocatechin-3-Gallate Inhibits Hepatoblastoma Growth by Reactivating the Wnt Inhibitor SFRP1

REFERENCES

• Mann , J R , Kasthuri , N , Raafat , F , Pincott , J R Parkes , S E . 1990 . Malignant hepatic tumours in children: incidence, clinical features and aetiology . Paediatr Perinat Epidemiol , 4 : 276 – 289 .
   PubMedGoogle Scholar
• Haberle , B , Bode , U and von Schweinitz , D . 2003 . Differentiated treatment protocols for high- and standard-risk hepatoblastoma—an interim report of the German Liver Tumor Study HB99 . Klin Padiatr , 215 : 159 – 165 .
   PubMed Web of Science ®Google Scholar
• Perilongo , G , Maibach , R , Shafford , E , Brugieres , L Brock , P . 2009 . Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma . N Engl J Med , 361 : 1662 – 1670 .
   PubMed Web of Science ®Google Scholar
• Zsiros , J , Maibach , R , Shafford , E , Brugieres , L Brock , P . 2010 . Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study . J Clin Oncol , 28 : 2584 – 2590 .
   PubMed Web of Science ®Google Scholar
• Cairo , S , Armengol , C , De Reynies , A , Wei , Y Thomas , E . 2008 . Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer . Cancer Cell , 14 : 471 – 484 .
   PubMed Web of Science ®Google Scholar
• Klaus , A and Birchmeier , W . 2008 . Wnt signalling and its impact on development and cancer . Nat Rev Cancer , 8 : 387 – 398 .
   PubMed Web of Science ®Google Scholar
• Buendia , M A . 2002 . Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects . Med Pediatr Oncol , 39 : 530 – 535 .
   PubMedGoogle Scholar
• Miao , J , Kusafuka , T , Udatsu , Y and Okada , A . 2003 . Sequence variants of the Axin gene in hepatoblastoma . Hepatol Res , 25 : 174 – 179 .
   PubMed Web of Science ®Google Scholar
• Taniguchi , K , Roberts , L R , Aderca , I N , Dong , X Qian , C . 2002 . Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas . Oncogene , 21 : 4863 – 4871 .
   PubMed Web of Science ®Google Scholar
• Wirths , O , Waha , A , Weggen , S , Schirmacher , P Kuhne , T . 2003 . Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms’ tumors . Lab Invest , 83 : 429 – 434 .
   PubMed Web of Science ®Google Scholar
• Koch , A , Waha , A , Hartmann , W , Hrychyk , A Schuller , U . 2005 . Elevated expression of Wnt antagonists is a common event in hepatoblastomas . Clin Cancer Res , 11 : 4295 – 4304 .
   PubMed Web of Science ®Google Scholar
• Rattner , A , Hsieh , J C , Smallwood , P M , Gilbert , D J Copeland , N G . 1997 . A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors . Proc Natl Acad Sci U S A , 94 : 2859 – 2863 .
   PubMed Web of Science ®Google Scholar
• Gumz , M L , Zou , H , Kreinest , P A , Childs , A C Belmonte , L S . 2007 . Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma . Clin Cancer Res , 13 : 4740 – 4749 .
   PubMed Web of Science ®Google Scholar
• Caldwell , G M , Jones , C , Gensberg , K , Jan , S Hardy , R G . 2004 . The Wnt antagonist sFRP1 in colorectal tumorigenesis . Cancer Res , 64 : 883 – 888 .
   PubMed Web of Science ®Google Scholar
• Graham , H N . 1992 . Green tea composition, consumption, and polyphenol chemistry . Prev Med , 21 : 334 – 350 .
   PubMed Web of Science ®Google Scholar
• Sharangi , A B . 2009 . Medicinal and therapeutic potentialities of tea (Camellia sinensis)—a review . Food Research International , 42 : 529 – 535 .
   Web of Science ®Google Scholar
• Pillai , S P , Mitscher , L A , Menon , S R , Pillai , C A and Shankel , D M . 1999 . Antimutagenic/antioxidant activity of green tea components and related compounds . J Environ Pathol Toxicol Oncol , 18 : 147 – 158 .
   PubMedGoogle Scholar
• Liang , Y C , Lin-Shiau , S Y , Chen , C F and Lin , J K . 1999 . Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate . J Cell Biochem , 75 : 1 – 12 .
   PubMed Web of Science ®Google Scholar
• Yokoyama , S , Hirano , H , Wakimaru , N , Sarker , K P and Kuratsu , J . 2001 . Inhibitory effect of epigallocatechin-gallate on brain tumor cell lines in vitro . Neuro Oncol , 3 : 22 – 28 .
   PubMed Web of Science ®Google Scholar
• Hibasami , H , Achiwa , Y , Fujikawa , T and Komiya , T . 1996 . Induction of programmed cell death (apoptosis) in human lymphoid leukemia cells by catechin compounds . Anticancer Res , 16 : 1943 – 1946 .
   PubMed Web of Science ®Google Scholar
• Tang , S N , Singh , C , Nall , D , Meeker , D Shankar , S . 2010 . The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition . J Mol Signal , 5 : 14
   PubMedGoogle Scholar
• Wu , H , Xin , Y , Xiao , Y and Zhao , J . 2012 . Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts . Cancer Biother Radiopharm , 27 : 204 – 209 .
   PubMed Web of Science ®Google Scholar
• Dashwood , W M , Orner , G A and Dashwood , R H . 2002 . Inhibition of beta-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations . Biochem Biophys Res Commun , 296 : 584 – 588 .
   PubMed Web of Science ®Google Scholar
• Gao , Z , Xu , Z , Hung , M S , Lin , Y C Wang , T . 2009 . Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells . Anticancer Res , 29 : 2025 – 2030 .
   PubMed Web of Science ®Google Scholar
• Kim , J , Zhang , X , Rieger-Christ , K M , Summerhayes , I C Wazer , D E . 2006 . Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1 . J Biol Chem , 281 : 10865 – 10875 .
   PubMed Web of Science ®Google Scholar
• Pahlke , G , Ngiewih , Y , Kern , M , Jakobs , S Marko , D . 2006 . Impact of quercetin and EGCG on key elements of the Wnt pathway in human colon carcinoma cells . J Agric Food Chem , 54 : 7075 – 7082 .
   PubMed Web of Science ®Google Scholar
• Pietsch , T , Fonatsch , C , Albrecht , S , Maschek , H Wolf , H K . 1996 . Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma . Lab Invest , 74 : 809 – 818 .
   PubMed Web of Science ®Google Scholar
• Hartmann , W , Waha , A , Koch , A , Goodyer , C G Albrecht , S . 2000 . p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19 . Am J Pathol , 157 : 1393 – 1403 .
   PubMed Web of Science ®Google Scholar
• Lopez-Terrada , D , Cheung , S W , Finegold , M J and Knowles , B B . 2009 . Hep G2 is a hepatoblastoma-derived cell line . Hum Pathol , 40 : 1512 – 1515 .
   PubMed Web of Science ®Google Scholar
• Eichenmuller , M , von Schweinitz , D and Kappler , R . 2009 . Betulinic acid treatment promotes apoptosis in hepatoblastoma cells . Int J Oncol , 35 : 873 – 879 .
   PubMed Web of Science ®Google Scholar
• Korinek , V , Barker , N , Morin , P J , van Wichen , D de Weger , R . 1997 . Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma . Science , 275 : 1784 – 1787 .
   PubMed Web of Science ®Google Scholar
• Fang , M Z , Wang , Y , Ai , N , Hou , Z Sun , Y . 2003 . Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines . Cancer Res , 63 : 7563 – 7570 .
   PubMed Web of Science ®Google Scholar
• Imai , K , Suga , K and Nakachi , K . 1997 . Cancer-preventive effects of drinking green tea among a Japanese population . Prev Med , 26 : 769 – 775 .
   PubMed Web of Science ®Google Scholar
• Khan , N and Mukhtar , H . 2007 . Tea polyphenols for health promotion . Life Sci , 81 : 519 – 533 .
   PubMed Web of Science ®Google Scholar
• Pietta , P G , Simonetti , P , Gardana , C , Brusamolino , A Morazzoni , P . 1998 . Catechin metabolites after intake of green tea infusions . Biofactors , 8 : 111 – 118 .
   PubMed Web of Science ®Google Scholar
• Ullmann , U , Haller , J , Decourt , J P , Girault , N Girault , J . 2003 . A single ascending dose study of epigallocatechin gallate in healthy volunteers . J Int Med Res , 31 : 88 – 101 .
   PubMed Web of Science ®Google Scholar
• Chow , H H , Cai , Y , Hakim , I A , Crowell , J A Shahi , F . 2003 . Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals . Clin Cancer Res , 9 : 3312 – 3319 .
   PubMed Web of Science ®Google Scholar
• Ahmad , N , Gupta , S and Mukhtar , H . 2000 . Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells . Arch Biochem Biophys , 376 : 338 – 346 .
   PubMed Web of Science ®Google Scholar
• Chen , Z P , Schell , J B , Ho , C T and Chen , K Y . 1998 . Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts . Cancer Lett , 129 : 173 – 179 .
   PubMed Web of Science ®Google Scholar
• Suzuki , Y , Miyoshi , N and Isemura , M . 2012 . Health-promoting effects of green tea . Proc Jpn Acad Ser B Phys Biol Sci , 88 : 88 – 101 .
   PubMed Web of Science ®Google Scholar
• Saeki , K , Kobayashi , N , Inazawa , Y , Zhang , H Nishitoh , H . 2002 . Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis . Biochem J , 368 : 705 – 720 .
   PubMed Web of Science ®Google Scholar
• Min , N Y , Kim , J H , Choi , J H , Liang , W Ko , Y J . 2012 . Selective death of cancer cells by preferential induction of reactive oxygen species in response to (-)-epigallocatechin-3-gallate . Biochem Biophys Res Commun , 421 : 91 – 97 .
   PubMed Web of Science ®Google Scholar
• Shanafelt , T D , Call , T G , Zent , C S , Leis , J F Laplant , B . 2013 . “ Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia ” . In Cancer Vol. 119 , 363 – 370 .
   Google Scholar
• Takahashi-Yanaga , F and Sasaguri , T . 2007 . The Wnt/beta-catenin signaling pathway as a target in drug discovery . J Pharmacol Sci , 104 : 293 – 302 .
   PubMed Web of Science ®Google Scholar
• Sakamoto , L H , de Camargo , B , Cajaiba , M , Soares , F A and Vettore , A L . 2010 . MT1G hypermethylation: a potential prognostic marker for hepatoblastoma . Pediatr Res , 67 : 387 – 393 .
   PubMed Web of Science ®Google Scholar
• Nandakumar , V , Vaid , M and Katiyar , S K . 2011 . (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells . Carcinogenesis , 32 : 537 – 544 .
   PubMed Web of Science ®Google Scholar
• Hagemann , S , Heil , O , Lyko , F and Brueckner , B . 2011 . Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines . PLoS One , 6 : e17388
   PubMed Web of Science ®Google Scholar
• Ugolini , F , Adelaide , J , Charafe-Jauffret , E , Nguyen , C Jacquemier , J . 1999 . Differential expression assay of chromosome arm 8p genes identifies frizzled-related (FRP1/FRZB) and fibroblast growth factor receptor 1 (FGFR1) as candidate breast cancer genes . Oncogene , 18 : 1903 – 1910 .
   PubMed Web of Science ®Google Scholar